# Master Protocols:  Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics Guidance for Industry:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/master-protocols-efficient-clinical-trial-design-strategies-to-expedite-development-of-oncology-drugs-and-biologics-guidance-for-industry-guidance-for-industry/102e00b9-5d33-4bc1-ac6f-2d1c86b63720

> FDA guidance document: Master Protocols:  Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics Guidance for Industry:  Guidance for Industry. Issue date: March 01, 2022. Get complete insights and analysis.

---

## Details

- Title: Master Protocols:  Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics Guidance for Industry:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-03-01
- Comment Close Date: 2018-11-30
- Last Changed: 2024-04-11
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-3292">FDA-2018-D-3292</a>

## Related Documents

- [Bladder Cancer: Developing Drugs and Biologics for Adjuvant Treatment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/bladder-cancer-developing-drugs-and-biologics-for-adjuvant-treatment-guidance-for-industry/b3fd959c-72c5-4e86-a4a9-5fa31d0ce7b7)
- [Cancer Clinical Trial Eligibility Criteria: Available Therapy in Non-Curative Settings:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-available-therapy-in-non-curative-settings-guidance-for-industry/d21a3c21-c758-4f3f-b215-edfe13aa09a3)
- [Expansion Cohorts: Use in First-In-Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/expansion-cohorts-use-in-first-in-human-clinical-trials-to-expedite-development-of-oncology-drugs-and-biologics-guidance-for-industry-guidance-for-industry/c3a82e7e-71fa-4de1-a294-c42a2c2954cd)